Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tuberin activates the proapoptotic molecule BAD.

A Freilinger1, M Rosner, G Krupitza

  • 1Medical Genetics, Obstetrics and Gynecology, Medical University of Vienna, Währinger Gürtel, Vienna, Austria.

Oncogene
|May 17, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IL1R1<sup>+</sup> cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer.

Nature communications·2023
Same author

Search for the optimal genotoxicity assay for routine testing of chemicals: Sensitivity and specificity of conventional and new test systems.

Mutation research. Genetic toxicology and environmental mutagenesis·2022
Same author

Ultrasound for the detection of the pyramidal lobe of the thyroid gland.

Journal of endocrinological investigation·2022
Same author

CDC25A Mediates Survival by Activating AKT Kinase.

TheScientificWorldJournal·2018
Same author

Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression.

Oncogene·2017
Same author

Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms.

Oncogene·2017

Tuberin, a protein involved in tuberous sclerosis (TSC), triggers apoptosis by inhibiting cell growth pathways. Mutations in TSC2 impair this function, highlighting tuberin

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • Tuberous sclerosis (TSC) is an autosomal dominant disorder affecting approximately 1 in 6000 individuals, characterized by hamartoma development.
  • TSC is caused by mutations in TSC1 (hamartin) and TSC2 (tuberin) tumor suppressor genes.
  • The hamartin-tuberin complex, with tuberin as the functional component, regulates cell cycle and cell size, and its defects contribute to tumor development via impaired apoptosis.

Purpose of the Study:

  • To investigate the role of tuberin in regulating apoptosis and its underlying molecular mechanisms.
  • To elucidate how tuberin's proapoptotic function is modulated by other cellular pathways, such as AKT and BAD.
  • To understand the pathophysiological relevance of tuberin's apoptotic function in TSC.

Main Methods:

Related Experiment Videos

  • Investigated tuberin's effect on apoptosis induction in cellular models.
  • Assessed the impact of tuberin on p70S6K activity, BAD phosphorylation, and BAD/BCL-2 family protein interactions.
  • Utilized BAD-/- cells to determine BAD's role as a mediator of tuberin's apoptotic effects.
  • Examined the influence of AKT phosphorylation on tuberin-induced apoptosis.
  • Analyzed the effect of insulin-like growth factor-1 (IGF-1) on BAD phosphorylation and cell survival in the context of tuberin.

Main Results:

  • Tuberin was shown to trigger apoptosis, accompanied by decreased p70S6K activity and BAD phosphorylation at Ser136.
  • Tuberin induced increased interaction between BAD and anti-apoptotic proteins BCL-2 and BCL-XL.
  • AKT phosphorylation was found to negatively regulate tuberin's proapoptotic activity.
  • BAD was confirmed as a crucial mediator of tuberin's apoptotic effects.
  • Tuberin interfered with IGF-1-induced BAD phosphorylation and cell survival.
  • A model was proposed where tuberin inhibits p70S6K, activating BAD for apoptosis, and TSC2 mutations attenuate this proapoptotic potential.

Conclusions:

  • Tuberin plays a critical role in inducing apoptosis, mediated by the BAD protein and inhibition of the p70S6K pathway.
  • AKT signaling negatively impacts tuberin's ability to promote apoptosis.
  • Impaired proapoptotic function of tuberin due to TSC2 mutations is relevant to the pathophysiology of tuberous sclerosis.